Results 1 to 10 of about 53,825 (265)

Schistosomiasis with Pericardial Effusion. [PDF]

Eur J Case Rep Intern Med
Schistosomiasis, caused by parasitic flatworms of the genus Schistosoma, is endemic in many areas of the world. We report the case of a young male patient presenting with persistent fever, abdominal pain, vomiting and diarrhoea, with travel history to Al Baha, Saudi Arabia, an endemic area for schistosomiasis.
Bajameel EK, Jamal A, Banjar AO, Alqahtani KM, Ahmed Elsheikh NB, Hussain Alkhuraim A.   +5 more
europepmc   +4 more sources

Pericardial Effusion

Ibom Medical Journal
Background: Pericardial effusion is defined as the accumulation of fluid in the pericardial sac, this can lead to life-threatening cardiac complications if not promptly diagnosed and managed effectively. This radiographic case study aims to demonstrate the crucial role of imaging techniques in diagnosing pericardial effusion, providing valuable ...
Willner DA, Goyal A, Grigorova Y, Sharma S, Kiel J.   +4 more
europepmc   +4 more sources

Massive Idiopathic Chronic Pericardial Effusion: A Case Report [PDF]

Journal of Cardio-Thoracic Medicine, 2023
An idiopathic chronic pericardial effusion which has occurred due to pericardial fluid collection can continue for over a three-month duration without obvious cause. Massive chronic pericardial effusion without cardiac tamponade is quite unusual.
Mahdi Kahrom, Masoomeh Tabari
doaj   +1 more source

Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report

Thoracic Cancer, 2021
In Japan, oral administration of tegafur‐uracil is recommended as postoperative adjuvant chemotherapy for patients diagnosed with primary lung adenocarcinomas of >2 cm size and staged as IA, IB, and IIA.
Nobutaka Kawamoto, Riki Okita, Masataro Hayashi, Masanori Okada, Hidetoshi Inokawa   +4 more
doaj   +1 more source

Pericardial effusion after congenital heart surgeryCentral MessagePerspective

JTCVS Open, 2022
Objective: Pericardial effusion after cardiac surgery remains an important cause of morbidity and mortality. We describe the risk factors of pericardial effusion after congenital heart surgery through analyzing data from a nationwide, multi-institutional
Mio Noma, MD, Yasutaka Hirata, MD, Norimichi Hirahara, PhD, Takaaki Suzuki, MD, Hiroaki Miyata, PhD, Yuji Hiramatsu, MD, Yukihiro Yoshimura, MD, Shinichi Takamoto, MD   +7 more
doaj   +1 more source

Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer

Frontiers in Genetics, 2022
Background: The feasibility and value of pericardial effusion as a liquid biopsy sample for actionable alteration detection in patients with non-small cell lung cancer (NSCLC) has not been adequately investigated.
Jiaxue He, Xintong Hu, Liguo Chen, Qiaoliang Liu, Yanfang Jiang   +4 more
doaj   +1 more source

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer

Radiation Oncology, 2020
Background The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking.
Tzu-Hui Pao, Wei-Lun Chang, Nai-Jung Chiang, Chia-Ying Lin, Wu-Wei Lai, Yau-Lin Tseng, Forn-Chia Lin   +6 more
doaj   +1 more source

Unveiling the causes of pericardial effusion in a contemporary case series of pericardiocentesis in Latin America

Scientific Reports, 2022
Pericardial effusions requiring pericardiocentesis have multiple causes that vary among geographical regions and health contexts. This procedure can be performed for diagnostic or therapeutic indications.
Juan Hernando del Portillo-Navarrete, Alejandro Pizano, Jhonattan Benavides, Andres M. Palacio, Karen Moreno-Medina, Jaime Cabrales, Darío Echeverri   +6 more
doaj   +1 more source

A case of tuberculous pericardial effusion confirmed by GeneXpert MTB/RIF combined with literature review [PDF]

Zhenduanxue lilun yu shijian, 2023
This paper reported a case of tuberculous pericardial effusion which was confirmed by GeneXpert MTB/RIF (Mycobacterium tuberculosis rpoB gene and mutation detection).
PENG Rong, LI Mu, MA Kuo, GONG Qian
doaj   +1 more source

Reduction of pericardial effusion in advanced non-small cell lung cancer patients with KRAS, TP53, and MET mutation treated with nivolumab

Journal of International Medical Research, 2020
Nivolumab is an immune checkpoint inhibitor that is used to treat various advanced cancers, including metastatic non-small cell lung cancer (NSCLC). Nivolumab treatment has different side effects.
Zhihui Cai, Yuan Yao
doaj   +1 more source